[1] Tehranzadeh J, Ashikyan O, Dascalos J. Advanced imaging of early rheumatoid arthritis[J]. Radiol Clin North Am, 2004, 42(1):89-107.
[2] Paleoloq EM. The vasculature in rheumatoid arthritis:cause or consequence?[J]. Int J Exp Pathol, 2009, 90(3):249-261.
[3] Szekanecz Z, Besenyei T, Szentpétery A, et al. Angiogenesis and vasculogenesis in rheumatoid arthritis[J]. Curr Opin Rheumatol, 2010, 22(3):299-306.
[4] Beer AJ, Niemeyer M, Carlsen J, et al. Patterns of alphavbeta3 ex-pression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET[J]. J Nucl Med, 2008, 49(2):255-259.
[5] Kenny LM, Coombes RC, Oulie I, et al. Phase I trial of the positron-emitting Arg-Gly-Asp(RGD) peptide radioligand 18F-AH111585 in breast cancer patients[J]. J Nucl Med, 2008, 49(6):879-886.
[6] Zhang L, Zhang CL, Yan P, et al. Design, preparation and charac-terization of cyclic RGD dimer for targeting integrin αVβ3[J]. J Converg Inform Technol, 2011, 6(12):442-450.
[7] Garrigues HJ, Rubinchikova YE, Dipersio CM, et al. Integrin al-phaVbeta3 binds to the RGD motif of glycoprotein B of kaposi's sarcoma-associated herpesvirus and functions as an RGD-depen-dent entry receptor[J]. J Virol, 2008, 82(3):1570-1580.
[8] Xu G, Nie H, Li N, et al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis[J]. J Clin Invest, 2005, 115(4):1060-1067.
[9] Ward PA. Inflammation and αvβ3 integrin[J]. Am J Respir Crit Care Med, 2012, 185(1):5-6.
[10] Somanath PR, Ciocea A, Byzova TV. Integrin and growth factor re-ceptor alliance in angiogenesis[J]. Cell Biochem Biophys, 2009, 53(2):53-64.
[11] Noda M, Inoue K, Kondo H, et al. Osteopontin in rheumatoid arthri-tis[J]. Nihon Rinsho, 2005, 63 Suppl 1:S185-188.
[12] Su G, Atakilit A, Li JT, et al. Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin forma-tion[J]. Am J Respir Crit Care Med, 2012, 185(1):58-66.
[13] Yamamoto N, Sakai F, Kon S, et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis[J]. J Clin Invest, 2003, 112(2):181-188.
[14] Hall H, Hubbell JA. Matrix-bound sixth Ig-like domain of cell ad-hesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2[J]. Microvasc Res, 2004, 68(3):169-178.
[15] Hoffmann S, He S, Jin M, et al. A selective cyclic integrin antago-nist blocks the integrin receptors αvβ3 and αvβ5 and inhibits reti-nal pigment epithelium cell attachment, migration and invasion[J]. BMC Ophthalmol, 2005, 5(5):16.
[16] Hsu AR, Veeravagu A, Cai W, et al. Integrin αvβ3 antagonists for anti-angiogenic cancer treatment[J]. Recent Pat Anticancer Drug Discov, 2007, 2(2):143-158.
[17] 苏云龙, 王雪梅, 赵爱玲, 等. 类风湿关节炎早期诊断的影像学方法研究进展[J]. 中华核医学与分子影像杂志, 2013, 33(2):157-160.
[18] Jia B, Liu Z, Zhu Z, et al. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD2 in non-human primates[J]. Mol Imaging Biol, 2011, 13(4):730-736.
[19] Ma Q, Ji B, Jia B, et al. Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy[J]. Eur J Nucl Med Mol Imaging, 2011, 38(12):2145-2152.
[20] Sherif HM, Saraste A, Nekolla SG, et al. Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodel-ing after myocardial infarction in rats[J]. J Nucl Med, 2012, 53(2):318-323.
[21] Hua J, Dobrucki LW, Sadeghi MM, et al. Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at αvβ3 integrin after murine hindlimb ischemia[J]. Circulation, 2005, 111(24):3255-3260.
[22] Zhu Z, Yin Y, Zheng K, et al. Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using 68Ga-PRGD2 PET/CT:a prospective proof-of-concept cohort study[J]. Ann Rheum Dis, 2014, 73(6):1269-1272.